Apac
  • Home
  • CXO Insights
  • CIO Views
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • About us
Apac
  • Admired Tech

    Agile

    AI Healthcare

    Artificial Intelligence

    Augmented Reality

    Aviation

    Big Data

    Blockchain

    Cloud

    Cryptocurrency

    Cyber Security

    DevOps

    Digital Transformation

    Drone

    HPC

    Infrared

    Internet of Things

    IT Services

    Marine Tech

    Networking

    PropTech

    Remote Work

    Robotics

    Scheduling Software

    Sensor Tech

    Simulation

    Smart City

    Software Testing

    Startup

    Storage

    Unified Communication

    Web Development

    Wireless

  • Automotive

    Banking

    Capital Market

    Construction

    E-Commerce

    Education

    FinTech

    Food and Beverages

    Gov and Public

    Healthcare

    Insurance

    Legal

    Logistics

    Manufacturing

    Media and Entertainment

    Metals and Mining

    Pharma and Life Science

    Retail

    Sports

    Travel and Hospitality

  • CISCO

    Google

    IBM

    Microsoft

    Oracle

    Salesforce

    SAP

    ServiceNow

  • Business Intelligence

    CEM

    Cloud-based Planning

    Cognitive

    Collaboration

    Compliance

    Contact Center

    Contact Tracing

    Contactless Payments

    Corporate Finance

    CRM

    Custom Software Development

    Data Center

    Digital Signage

    Enterprise Architecture

    Enterprise Asset Management

    Enterprise Communications

    Enterprise Contract Management

    Enterprise Performance Management

    ERP

    Facility Management

    Field Service

    Fleet Management

    Gamification

    HR Technology

    IT Infrastructure

    IT Service Management

    Managed Services

    PLM

    Procurement

    Product Management

    Project Management

    RegTech

    Revenue Management

    Sales Tech

Menu
    • CISCO
    • Collaboration
    • Compliance
    • Contact Center
    • Healthcare
    • IT Service Management
    • Microsoft
    • Retail
    • MORE
    #

    Apac CIO Outlook Weekly Brief

    ×

    Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIO Outlook

    Subscribe

    loading

    THANK YOU FOR SUBSCRIBING

    • Home
    • News
    • Pharma and Life Science
    Editor's Pick (1 - 4 of 8)
    left
    The 4Ps of Digital Transformation in Pharmaceutical Industry

    Debraj Dasgupta, Operating Officer, Head of Strategy and Go-To-Market Planning Division, Nippon Boehringer Ingelheim

    Cloud Computing: Pharma Takes the Plunge

    Andy Newsom, SVP & CIO, CSL Behring

    Machine Learning & Artificial Intelligence in Healthcare Industry

    James Woo, CIO, The Farrer Park Company

    Connected Patients: Healthcare and the Internet of Things

    Geoff Feakes, Group CIO, Tunstall Healthcare Group

    Building a Quality-Focused IT Foundation for a Biopharmaceutical Enterprise

    Andy Newsom, SVP, CIO, CSL Behring

    Points of Focus for CIOs to Succeed in the Next Decade and Beyond

    Dr. Joseph Frassica, CMIO/CTO, Patient Care and Monitoring Solutions, Philips Healthcare

    Innovating Technology -Based Metadata Solutions for Improved Data Analysis

    Douglas Barta, CIO, PAREXEL International

    Real-Time Actionable Intelligence with a Solid Analytics Platform

    Rajeev Nair,

    right

    The Cancer Diagnostic Firm, Pillar Biosciences Raises $29.7M in Series C Round of Financing

    By Apac CIO Outlook | Monday, July 06, 2020
    Tweet

    The Natick, Massachusetts, and Shanghai-based Biosciences Company raised $29.7M from its Series C round of financing

    Fremont, CA: The cancer diagnostic firm Pillar Biosciences closes a $29.7 Million Series C preferred stock financing round recently. ORI Healthcare Fund led the latest round of funding. The company also launched the CE marketing for its Onco/Reveal Dx lung and colon cancer in vitro diagnostic assay. 

    The Natick, Massachusetts-based assay developer, said it would use these funds to accelerate the widespread extension of its clinical and research-use next-gen sequencing panels and expand its global commercial reach. 

    "We are a strong believer in using NGS tumor testing to make precision medicine the first-line treatment," Simone Song, Senior Partner of ORI Healthcare Fund, said in a statement. "Pillar's Slimamp technology is fast, accurate, user friendly, and cost-effective. We have confidence that Pillar will fulfill an unmet medical need and bring true benefits to cancer patients."

    Top 10 Pharma Tech Solution Companies - 2019The Slimamp target enrichment chemistry offers a single tube that is an amplicon-based assay and is also compatible with Illumina, Thermo Fisher Scientific Ion Torrent, and MGI sequencing platforms. Pillar also provides services and bioinformatics tools that allow variant calling. 

    Previously, Pillar had received an $18 million investment from the same ORI Healthcare Fund in 2016 and has earlier signed a co-marketing agreement with BGI subsidiary MGI Tech along with an IVD development partnership contract with Illumina. 

    In 2019, the firm entered a joint venture contract with China Biotech Services Holdings to offer diagnostic products and services to the regions of Hong Kong, Macau, South Korea, and Southeast Asia. The same company, China Biotech Services Holdings, took part in the undisclosed Series B funding round by Pillar. 

    The company's custom product that gained approval from the New York State Department of Health guides the prescription of six varieties of therapies simultaneously, reducing the need for conducting repeat tests, and enables the treatment decisions to be made in 4 days.

    Pillar has also secured distributors in Israel, Hong Kong, Macau, South Korea, and ASEAN countries recently. 

    See also: Top Pharma Machinery Solution Companies

    tag

    Pharmaceutical

    Bioinformatics

    Weekly Brief

    loading
    ON THE DECK

    Content Management System 2020

    Top Vendors

    Contactless Payments 2020

    Top Vendors

    Admired Tech 2020

    Top Vendors

    Previous Next

    I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

    Read Also

    Leveraging CRM to Transform Leads Into Customers

    Leveraging CRM to Transform Leads Into Customers

    Major IoT Software Implementation Challenges

    Major IoT Software Implementation Challenges

    Key Advantages of Using Smart Home Technologies

    Key Advantages of Using Smart Home Technologies

    The Relevance of LMS in Education

    The Relevance of LMS in Education

    Advantages of Using the Microsoft Office Suite for Businesses

    Advantages of Using the Microsoft Office Suite for Businesses

    Three Shopping Trends in Fashion Industry

    Three Shopping Trends in Fashion Industry

    Loading...

    Copyright © 2021 APAC CIOoutlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy Policy  |  Sitemap |  Subscribe

    follow on linkedinfollow on twitter follow on rss
    This content is copyright protected

    However, if you would like to share the information in this article, you may use the link below:

    https://www.apacciooutlook.com/news/the-cancer-diagnostic-firm-pillar-biosciences-raises-297m-in-series-c-round-of-financing-nwid-7499.html